Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?

Objective  We investigated the effects of pravastatin on chylomicron remnant catabolism measured with a 13C stable isotope breath test and plasma apolipoprotein (apo) B‐48 and remnant‐like particle (RLP)‐cholesterol in postmenopausal women with type 2 diabetes mellitus.

[1]  G. Reaven,et al.  Role of insulin in regulation of lipoprotein metabolism in diabetes. , 1988, Diabetes/metabolism reviews.

[2]  R. Tilvis,et al.  Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. , 1990, American journal of epidemiology.

[3]  A. V. van Beek,et al.  Menopause is associated with reduced protection from postprandial lipemia. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[4]  J. Mamo.  Atherosclerosis as a postprandial disease , 1995 .

[5]  A. Chait,et al.  Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation. , 1979, The Journal of clinical investigation.

[6]  G. Watts,et al.  Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test. , 2001, Atherosclerosis.

[7]  K. Parhofer,et al.  Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients Published, JLR Papers in Press, April 1, 2003. DOI 10.1194/jlr.M300011-JLR200 , 2003, Journal of Lipid Research.

[8]  K. Nakajima,et al.  Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[9]  I. Martins,et al.  A 13CO2 breath test to assess the metabolism of triglyceride-rich lipoprotein remnants in mice. , 1998, Journal of lipid research.

[10]  R. Mahley,et al.  Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. , 1978, Biochemistry.

[11]  A. Thomson,et al.  Cholesterol esters regulate apoB48 secretion in CaCo2 cells. , 2002, Atherosclerosis.

[12]  K. Adeli,et al.  Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[13]  K. Cianflone,et al.  Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitor. , 1990, Metabolism: Clinical and Experimental.

[14]  A. Hamsten,et al.  Postprandial lipoproteins and progression of coronary atherosclerosis. , 1994, Atherosclerosis.

[15]  K. Einarsson,et al.  Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. , 1987, Journal of lipid research.

[16]  S M Grundy,et al.  Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Watts,et al.  Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus , 2003, Clinical endocrinology.

[18]  B. Davis,et al.  Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. , 1998, Circulation.

[19]  G. Tomkin,et al.  Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism? , 2000, Metabolism: clinical and experimental.

[20]  G. Watts,et al.  Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome. , 2003, Obesity research.

[21]  H. Kempen,et al.  Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. , 1988, Journal of lipid research.

[22]  T. D. de Bruin,et al.  17 beta-Estradiol improves postprandial lipid metabolism in postmenopausal women. , 1995, The Journal of clinical endocrinology and metabolism.

[23]  W C Willett,et al.  The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. , 2001, Archives of internal medicine.

[24]  G. Watts,et al.  Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome , 2003, International Journal of Obesity.

[25]  G. Watts,et al.  Postprandial dyslipidaemia in a nutshell: food for thought. , 1998, Australian and New Zealand journal of medicine.

[26]  J. Ramires,et al.  Effect of pravastatin on plasma removal of a chylomicron-like emulsion in men with coronary artery disease. , 2000, The American journal of cardiology.

[27]  G. Watts,et al.  Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test. , 2002, Journal of lipid research.

[28]  A. Tall,et al.  Effect of biliary diversion on rat mesenteric lymph apolipoprotein-I and high density lipoprotein. , 1982, The Journal of clinical investigation.

[29]  K. Maeda,et al.  Bile Salt Export Pump (BSEP/ABCB11) Can Transport a Nonbile Acid Substrate, Pravastatin , 2005, Journal of Pharmacology and Experimental Therapeutics.

[30]  R. Martins,et al.  Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice. , 2000, Journal of lipid research.

[31]  J. Ramires,et al.  Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins. , 2003, Atherosclerosis.

[32]  R. Mahley,et al.  Lipoprotein receptors and cholesterol homeostasis. , 1983, Biochimica et biophysica acta.

[33]  W. Duane.  Serum lathosterol levels in human subjects reflect changes in whole body cholesterol synthesis induced by lovastatin but not dietary cholesterol. , 1995, Journal of lipid research.

[34]  G. Watts,et al.  Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test. , 2001, Journal of lipid research.